版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、How to accelerate AD research 2022-5-82ContentsCurrent situation of AD1What are big companies doing 2Trends3Perspective42022-5-831 Current situation of ADvPopulation:37 million vCauses:too sophisticatedvMarket drugs:Tarcrine,Donepezil,Rivastigmine,Galanthamine,Huperzine,MemantinevSome social activit
2、ies may correlate with AD,but cannot delay the progress of AD2022-5-84Nature Reviews.2010.7:387-3982022-5-852 What are big companies doingvA big cake attracts a lot of big companies,attention,such as Pfizer,Elan,Merk,Novartis and so on2022-5-86BMC Medicine 2009, 7:7 2022-5-87TramiprosatevALZHEMED(Ne
3、urochem Inc.) vThe Phase III trial did not show a beneficial effect on cognition or function,so the development program has been discontinued 2022-5-88Vaccines and antibodiesvAN-1792(Elan)the first-generation amyloid vaccine,Phase II trial was discontinued owing to the development of aseptic meningo
4、encephalitis in 6% of the patientsvACC-001(Elan)prevent the induction of a toxic cellular immune response,in a Phase II clinical trialvBapineuzumab (Elan/Wyeth) :Phase III,monoclonal antibodiesvImmunoglobulin IgIV:Phase III,polyclonal antibodies2022-5-892022-5-810RAGE InhibitorvAmyloid is known to b
5、ind to receptors for advanced glycated endproducts (RAGE) on the surface of cells and at the blood-brain barrier; this binding may contribute to inflammation and neuronal death.vPF-04494700 :an orally bioavailable antagonist of RAGE,Phase II 2022-5-811-secretase inhibitorsvTarenflurbil:the enantiome
6、r of the non-steroidal anti-inflammatory drug flurbiprofen,modulates the activity of -secretase,failed in Phase III vSemagacestat:reduction of amyloid peptide generation in blood and cerebrospinal fluid of patients with AD treated with tolerable doses, in Phase III2022-5-812Tau aggregation inhibitor
7、vRember(Methylene blue):a widely used histology dye, has been shown to interfere with tau aggregation.v Entering Phase III2022-5-8132022-5-814Microtubule stabilizervNAP (AL-108):derived from a natural neurotrophic protein, can be delivered to the central nervous system via intranasal administration.
8、vmarkedly reduces tau phosphorylation, and preliminary human studies have been encouraging.Now it is in Phase II trial.2022-5-815Dimebon-Pfizerv Phase III trial(Dimebon and Donepezil): failed,but Pfizer now is launching another Phase III trial about dimebon with other AD drugs.NNN2022-5-816vPhase II
9、I trials of Ginkgo biloba, NSAIDs, phenserine, statins, tarenflurbil, tramiprosate, and xaliproden have been completed, none of them demonstrating adequate efficacy.vPhase II trials of dimebon, huperzine A, intravenous immunoglobulin, and methylthioninium chloride were reported at 2008. vNineteen co
10、mpounds are currently in Phase II trials, and 3 compounds (AN1792, lecozotan SR, and SGS742) failed at this stage of development.2022-5-8173 TrendsvMultitarget Anti-Alzheimer AgentsvAD modelvfurther explore the causesvcoalition and cooperation2022-5-818Multitarget Anti-Alzheimer AgentsNovel Tacrine-
11、8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimers Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties2022-5-8192022-5-820Bivalent -Carbolines as Potential Multitarget Anti-Alzheimer Agents2022-5-821AD modelvA platform to perfor
12、m pharmacological evaluation of animal models of Alzheimers diseasevIn the future drug candidates may be directly used to animal models of Alzheimers disease2022-5-822Further explore the causesThe brain of AD patient likes a labyrinth 2022-5-823CooperationvWhile each of us is running into a stone wa
13、ll with Alzheimers ,what will we do next?vAllow researchers to study a larger pool of patients will help us see how the disease progresses, identify subgroups, and hopefully develop more sophisticated computer models that could save time and money developing drugs.2022-5-8244 PerspectivevWhile it is
14、 not possible to predict the success of any individual program, one or more are likely to prove effective.vDespite disappointing results from recently completed Phase III trials of several novel compounds, the extent and breadth of activity at all phases of clinical development suggest that new phar
15、macotherapeutic options for the treatment of AD will become available within the next decade. vIt seems reasonable to predict that in the not-too-distant future, a synergistic combination of agents will have the capacity to alter the neurodegenerative cascade and reduce the global impact of this dev
16、astating disease.2022-5-826Reference1 Michael S Rafii and Paul S Aisen.Recent developments in Alzheimers disease therapeutics.BMC Medicine 2009, 7:7 ,1741-7-15.2 Yvonne Rook.Bivalent -Carbolines as Potential Multitarget Anti-Alzheimer Agents.J.Med.C.XXXX,Vol.XXX,NO.XX3 Mara Isabel Fern andez-Bachill
17、er.Novel Tacrine-8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimers Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties.J.Med.C.XXXX,XXX,000-000.4 Raymond T. Bartus & Reginald L. Dean III.Pharmaceutical treatment for cognitive deficits in Alzheimers disease and other neurodegenerative conditions:exploring new territory using traditional tools and established maps.Psychopharmacology (2009) 202:
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024年散料搬运设备项目合作计划书
- 北京市国电系统-2023年《变电安规》科目 单选题+多选题+判断题+简答题真题冲刺卷3月份A卷
- 2024年刀剪及类似日用金属工具项目合作计划书
- 2024年拖拉机及农林牧渔用挂车合作协议书
- 三心俱全察世界 一腔热爱悟生活-《热爱写作学会观察》教学设计-七年级语文上册同步高效课堂(统编版)
- 运城市2024-2025 学年高三摸底调研测试(一模) 历史试卷(含答案)
- 电梯安装改造安全操作规程
- 封阳台换窗户免责协议书
- 浙教版七年级科学上学期期末培优冲刺专题07比热和物质的三态变化专题特训(原卷版+解析)
- 五年级上册数学培优奥数讲义-第9讲 解方程
- 水泥厂危险源辨识
- ×××煤矿现场三大员管理考核办法
- 新概念青少版2B知识点复习
- 能源消耗统计台账
- 外墙保温找平施工方案
- 2022年土地估价师土地估价实务土地估价期日的设定试题
- 特种设备作业人员培训记录表
- 2022江苏省录用公务员考试行测C类真题卷及答案
- 祖国不会忘记合唱谱-经典珍藏版
- 主题班会 节约用电 课件 (22张PPT)
- 消防安全培训及应急演练主题教育课件PPT模板宣传PPT动态PPT
评论
0/150
提交评论